Skip to main content

Table 1 Distribution of clinically and genetically relevant variables in a cohort of women at baseline of the observational period 1993 – 2003. The total number of women in this analysis is 4320, i.e. excluding 17 women with a final diagnosis of a possible/potential VTE. Deviations from this number are due to missing information

From: Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: A community-based cohort study

Variables

   

Continuous variables

 

n

Mean (SD)

Age (years)

 

4320

26.0 (8.6)

Life births, number

 

1910

1.7 (0.8)

BMI§

 

4309

23.3 (4.1)

Protein C (% of normal)

 

4315

102.4 (15.8)

AT (% of normal)

 

4316

98.4 (11.3)

Categorical parameters

  

Percent (%)

Own history of VTE

No

4279

99.0

 

Yes

41

1.0

Family history

No

3840

88.9

 

Yes

480

11.1

Age, alternative

<30

2843

65.8

 

≥ 30

1477

34.2

Family history of varicous veins

No

2395

55.4

 

Yes

1925

44.6

Family history of MI

No

3830

88.7

 

Yes

490

11.3

BMI, alternative

<25

3218

74.7

 

≥ 25

1091

25.3

Ever use of hormone replacement

No

4031

93.7

 

Yes

270

6.3

Family history of stroke

No

4013

92.9

 

Yes

307

7.1

Ever use of oral contraceptives

No

346

8.0

 

Yes

3973

92.0

Education level: Abitur&

No

3119

73.2

 

Yes

1139

26.8

Ever smoker

No

2022

46.8

 

Yes

2296

53.2

Laboratory & genetic markers

   

Factor V Leiden mutation1

No

4035

93.7

 

Yes

271

6.3

Prothrombin mutation1

No

4088

96.6

 

Yes

142

3.4

MTHFR1

No

1798

42.5

 

Yes

2432

57.5

Protein C deficiency#

No

4117

95.4

 

Yes

198

4.6

AT deficiency#

No

4106

95.1

 

Yes

210

4.9

  1. 1 Homozygote & heterozygote together
  2. §
  3. Body mass index (kg/m2)
  4. &maturity for university
  5. # definition see methods